Analysis of clinical, dosimetric and radiomic features for predicting local failure after stereotactic radiotherapy of brain metastases in malignant melanoma
0
🔗
Sign in to get full access
Overview
- This study aimed to investigate the role of clinical, dosimetric, and pretherapeutic magnetic resonance imaging (MRI) features for predicting the outcome of stereotactic radiotherapy (SRT) in patients with brain metastases from malignant melanoma (MBM).
- The researchers analyzed 517 MBM lesions from 130 patients treated with SRT, evaluating clinical parameters, radiation dose, and radiomic features (RF) extracted from pretherapeutic contrast-enhanced T1-weighted MRI.
- The study found that certain clinical, dosimetric, and radiomic features, particularly those related to the environment around the tumor, could predict the likelihood of local failure (LF) after SRT.
Plain English Explanation
The researchers wanted to understand what factors might help predict how well stereotactic radiotherapy (a specialized type of radiation treatment) would work for patients with brain metastases from melanoma. They looked at things like the patients' clinical information, the radiation doses used, and features extracted from MRI scans of the tumors.
By analyzing data from over 500 tumor lesions in 130 patients, the researchers found that certain characteristics were associated with a higher risk of the tumor not responding well to the radiation treatment. For example, features related to the area around the tumor, rather than just the tumor itself, seemed to be important. The researchers also found that whether the patient had received other systemic treatments before the radiation therapy was a factor in predicting the outcome.
The key takeaway is that looking at the full context around the tumor, not just the tumor itself, may provide important information to help personalize radiation treatment plans for patients with brain metastases from melanoma.
Technical Explanation
The researchers conducted a multicenter, retrospective analysis of 517 brain metastases from malignant melanoma (MBM) in 130 patients who underwent stereotactic radiotherapy (SRT). They calculated 1,576 radiomic features for each gross tumor volume (GTV), including features from the GTV itself and a 3 mm margin around the GTV.
They evaluated the clinical parameters, radiation dose, and radiomic features extracted from pretherapeutic contrast-enhanced T1-weighted MRI, using a feature processing and elimination pipeline in a nested cross-validation scheme. The goal was to identify features that could predict the likelihood of local failure (LF) after SRT.
The results showed that 72 out of 517 lesions (13.9%) experienced LF. The analysis identified several prominent features associated with predicting LF, including the correlation of the gray level co-occurrence matrix of the tumor margin (hazard ratio 0.37) and whether the patient had received systemic therapy before SRT (hazard ratio 0.55). Interestingly, the majority of radiomic features linked to LF were calculated in the margin around the GTV, rather than the tumor itself.
Critical Analysis
The study provides valuable insights into the potential of using pretherapeutic MRI analysis, including radiomic features, to predict outcomes for stereotactic radiotherapy in patients with brain metastases from melanoma. The use of a multicenter dataset and the focus on the tumor environment, rather than just the tumor, are notable strengths.
However, the study also has some limitations. The retrospective nature and potential differences in imaging protocols across institutions could introduce biases. Additionally, the study does not provide detailed information on the specific systemic therapies received by patients, which may have influenced the radiotherapy outcomes.
Further research is needed to validate the findings in larger, prospective cohorts and to better understand the mechanistic links between the identified radiomic features and treatment response. Incorporating segmentation-free outcome prediction approaches or novel brain MRI asymmetry-specific features may also help refine the predictive models.
Conclusion
This study demonstrates the potential of using pretherapeutic MRI-based radiomic analysis, in combination with clinical and dosimetric factors, to predict the outcomes of stereotactic radiotherapy in patients with brain metastases from melanoma. The findings suggest that the tumor environment may play a crucial role in treatment response, highlighting the importance of considering the full context around the tumor when developing personalized radiotherapy strategies for this patient population.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
🔗
0
Analysis of clinical, dosimetric and radiomic features for predicting local failure after stereotactic radiotherapy of brain metastases in malignant melanoma
Nanna E. Hartong, Ilias Sachpazidis, Oliver Blanck, Lucas Etzel, Jan C. Peeken, Stephanie E. Combs, Horst Urbach, Maxim Zaitsev, Dimos Baltas, Ilinca Popp, Anca-Ligia Grosu, Tobias Fechter
Background: The aim of this study was to investigate the role of clinical, dosimetric and pretherapeutic magnetic resonance imaging (MRI) features for lesion-specific outcome prediction of stereotactic radiotherapy (SRT) in patients with brain metastases from malignant melanoma (MBM). Methods: In this multicenter, retrospective analysis, we reviewed 517 MBM from 130 patients treated with SRT (single fraction or hypofractionated). For each gross tumor volume (GTV) 1576 radiomic features (RF) were calculated (788 each for the GTV and for a 3 mm margin around the GTV). Clinical parameters, radiation dose and RF from pretherapeutic contrast-enhanced T1-weighted MRI from different institutions were evaluated with a feature processing and elimination pipeline in a nested cross-validation scheme. Results: Seventy-two (72) of 517 lesions (13.9%) showed a local failure (LF) after SRT. The processing pipeline showed clinical, dosimetric and radiomic features providing information for LF prediction. The most prominent ones were the correlation of the gray level co-occurrence matrix of the margin (hazard ratio (HR): 0.37, confidence interval (CI): 0.23-0.58) and systemic therapy before SRT (HR: 0.55, CI: 0.42-0.70). The majority of RF associated with LF was calculated in the margin around the GTV. Conclusions: Pretherapeutic MRI based RF connected with lesion-specific outcome after SRT could be identified, despite multicentric data and minor differences in imaging protocols. Image data analysis of the surrounding metastatic environment may provide therapy-relevant information with the potential to further individualize radiotherapy strategies.
Read more6/3/2024
0
BrainMetDetect: Predicting Primary Tumor from Brain Metastasis MRI Data Using Radiomic Features and Machine Learning Algorithms
Hamidreza Sadeghsalehi
Objective: Brain metastases (BMs) are common in cancer patients and determining the primary tumor site is crucial for effective treatment. This study aims to predict the primary tumor site from BM MRI data using radiomic features and advanced machine learning algorithms. Methods: We utilized a comprehensive dataset from Ocana-Tienda et al. (2023) comprising MRI and clinical data from 75 patients with BMs. Radiomic features were extracted from post-contrast T1-weighted MRI sequences. Feature selection was performed using the GINI index, and data normalization was applied to ensure consistent scaling. We developed and evaluated Random Forest and XGBoost classifiers, both with and without hyperparameter optimization using the FOX (Fox optimizer) algorithm. Model interpretability was enhanced using SHAP (SHapley Additive exPlanations) values. Results: The baseline Random Forest model achieved an accuracy of 0.85, which improved to 0.93 with FOX optimization. The XGBoost model showed an initial accuracy of 0.96, increasing to 0.99 after optimization. SHAP analysis revealed the most influential radiomic features contributing to the models' predictions. The FOX-optimized XGBoost model exhibited the best performance with a precision, recall, and F1-score of 0.99. Conclusion: This study demonstrates the effectiveness of using radiomic features and machine learning to predict primary tumor sites from BM MRI data. The FOX optimization algorithm significantly enhanced model performance, and SHAP provided valuable insights into feature importance. These findings highlight the potential of integrating radiomics and machine learning into clinical practice for improved diagnostic accuracy and personalized treatment planning.
Read more7/9/2024
🔗
0
Towards robust radiomics and radiogenomics predictive models for brain tumor characterization
Maria Nadeem, Asma Shaheen, Muhammad F. A. Chaudhary, Hassan Mohy-ud-Din
In the context of brain tumor characterization, we focused on two key questions: (a) stability of radiomics features to variability in multiregional segmentation masks obtained with fully-automatic deep segmentation methods and (b) subsequent impact on predictive performance on downstream tasks: IDH prediction and Overall Survival (OS) classification. We further constrained our study to limited computational resources setting which are found in underprivileged, remote, and (or) resource-starved clinical sites in developing countries. We employed seven SOTA CNNs which can be trained with limited computational resources and have demonstrated superior segmentation performance on BraTS challenge. Subsequent selection of discriminatory features was done with RFE-SVM and MRMR. Our study revealed that highly stable radiomics features were: (1) predominantly texture features (79.1%), (2) mainly extracted from WT region (96.1%), and (3) largely representing T1Gd (35.9%) and T1 (28%) sequences. Shape features and radiomics features extracted from the ENC subregion had the lowest average stability. Stability filtering minimized non-physiological variability in predictive models as indicated by an order-of-magnitude decrease in the relative standard deviation of AUCs. The non-physiological variability is attributed to variability in multiregional segmentation maps obtained with fully-automatic CNNs. Stability filtering significantly improved predictive performance on the two downstream tasks substantiating the inevitability of learning novel radiomics and radiogenomics models with stable discriminatory features. The study (implicitly) demonstrates the importance of suboptimal deep segmentation networks which can be exploited as auxiliary networks for subsequent identification of radiomics features stable to variability in automatically generated multiregional segmentation maps.
Read more6/12/2024
💬
0
The University of California San Francisco Brain Metastases Stereotactic Radiosurgery (UCSF-BMSR) MRI Dataset
Jeffrey D. Rudie, Rachit Saluja, David A. Weiss, Pierre Nedelec, Evan Calabrese, John B. Colby, Benjamin Laguna, John Mongan, Steve Braunstein, Christopher P. Hess, Andreas M. Rauschecker, Leo P. Sugrue, Javier E. Villanueva-Meyer
The University of California San Francisco Brain Metastases Stereotactic Radiosurgery (UCSF-BMSR) dataset is a public, clinical, multimodal brain MRI dataset consisting of 560 brain MRIs from 412 patients with expert annotations of 5136 brain metastases. Data consists of registered and skull stripped T1 post-contrast, T1 pre-contrast, FLAIR and subtraction (T1 pre-contrast - T1 post-contrast) images and voxelwise segmentations of enhancing brain metastases in NifTI format. The dataset also includes patient demographics, surgical status and primary cancer types. The UCSF-BSMR has been made publicly available in the hopes that researchers will use these data to push the boundaries of AI applications for brain metastases. The dataset is freely available for non-commercial use at https://imagingdatasets.ucsf.edu/dataset/1
Read more6/3/2024